The Morning Brief - A Brief Review of Sita Lipton's Patent Expiry

Sita lipton's patent expiry is not a panitia to solve the problems of rising cost of deputy's care. The fact that there are at least three more dabetic treatment drugs going off pattent in the next two to three years brings more good news for patients fighting high sugar problems. We have to make sure our local and central governments do not ease their attention and spending on health care. You have been listening to dabutys drugs, bitter sweet ruth of patent expieties with me. Kirenso munshe on the morning breeze.